How to Report a Stem Cell Clinic to the FDA

Reporting a stem cell clinic means telling a regulator about a suspected problem, such as a bad reaction after a procedure, a misleading claim, or a product you believe is being sold improperly. In the United States, the FDA oversees the safety of medical products, and it runs a public safety reporting program called MedWatch.

It helps to know the regulatory picture. Blood-forming stem cell transplants from cord blood or bone marrow, used for certain cancers and blood disorders, are the clearly FDA-approved use. Stem cell, MSC, bone marrow aspirate, adipose-derived, umbilical cord or Wharton's jelly, and exosome products marketed for joints, back pain, sports injuries, skin, anti-aging or hair loss are generally not FDA-approved for those uses, and the FDA has warned the public about unapproved stem cell clinics and products.

Reported risk categories with unapproved products include infection, immune reaction, tumor formation at the injection site, and permanent injury when products are injected into the eye or spine. Reporting does not diagnose anything. It simply gives regulators information they may use to look into a concern.

Safety reporting has long been a shared effort. Patients, caregivers and health professionals can all send reports about adverse events or product concerns to the FDA through MedWatch, which is how regulators may spot patterns over time.

Separately, the practice of medicine is overseen at the state level. A state medical board generally handles complaints about a licensed physician's conduct, such as misleading claims, inadequate consent or substandard care. Other licensed professionals typically have their own state boards.

Many people begin by gathering their records: consent paperwork, receipts, marketing materials, product names or lot information if they were given any, dates of visits, and notes on symptoms afterward. Keeping copies and writing down what happened while it is fresh is a common first step. Look for the current reporting instructions on the FDA's and your state board's official websites rather than relying on third-party pages.

Before anything else, if you are having a health problem after a procedure, see a licensed clinician promptly. A provider such as a primary care doctor or a specialist in the affected area may evaluate you, document what is happening, and tell you what care is appropriate. For emergencies call 911.

A visit like this is generally a conversation and an exam. You may be asked what was injected or given, where, and when, along with your symptoms and medical history. Bringing your paperwork helps. Useful questions include: Can you document this in my record? Should I follow up with the original clinic or someone else? Would you be willing to submit a MedWatch report or advise me on submitting my own?

If you are still choosing a provider, use this red-flag checklist: guarantees of results; 'cure' or 'regrow' language; refusal to name the exact product or its FDA status; pressure to decide quickly; and discouraging a second opinion. Informed consent should cover the exact product and its FDA status, specific risks, a realistic chance of benefit, alternatives including doing nothing, total cost disclosure, and your right to walk away. This page is not a consent form. Treatment abroad is materially higher risk because safety, sourcing and regulatory standards differ and complications are harder to address from a distance, so a vetted domestic provider is a safer first step. A registered clinical trial, found through ClinicalTrials.gov, is a legitimate route to experimental care.